In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...

A mouse study showed a link between an infection with herpes simplex virus type 1 (HSV-1), the cause of cold sores, and MS.

Alzheimer's disease, affecting millions, is projected to surge by 2050. Research suggests a potential link between herpes ...

SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

A deft uveitis diagnosis can help reveal underlying systemic infections, neoplastic conditions, and other systemic illnesses.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and Drug Administration (FDA) approved the first virus-based cancer therapy, ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.